| Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis S Ramanathan, SW Reddel, A Henderson, JDE Parratt, M Barnett, ... Neurology-Neuroimmunology Neuroinflammation 1 (4), 2014 | 247 | 2014 |
| The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease GP Parnell, PN Gatt, M Krupa, D Nickles, FC McKay, SD Schibeci, ... Clinical immunology 151 (1), 16-24, 2014 | 67 | 2014 |
| The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells F Shahijanian, GP Parnell, FC McKay, PN Gatt, M Shojoei, KS O'Connor, ... Human molecular genetics 23 (6), 1425-1434, 2014 | 51 | 2014 |
| The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis NL Fewings, PN Gatt, FC McKay, GP Parnell, SD Schibeci, J Edwards, ... Journal of autoimmunity 78, 57-69, 2017 | 39 | 2017 |
| Long‐term reversal of diabetes in non‐obese diabetic mice by liver‐directed gene therapy B Ren, BA O'Brien, MR Byrne, E Ch'ng, PN Gatt, MA Swan, NT Nassif, ... The journal of gene medicine 15 (1), 28-41, 2013 | 36 | 2013 |
| Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study S Mahurkar, M Moldovan, V Suppiah, M Sorosina, F Clarelli, G Liberatore, ... The pharmacogenomics journal 17 (4), 312, 2017 | 30 | 2017 |
| The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies FC McKay, PN Gatt, N Fewings, GP Parnell, SD Schibeci, MAI Basuki, ... Clinical Immunology 163, 96-107, 2016 | 29 | 2016 |
| Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season GP Parnell, PN Gatt, FC McKay, S Schibeci, M Krupa, JE Powell, ... Multiple Sclerosis Journal 20 (6), 675-685, 2014 | 26 | 2014 |
| IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent FC McKay, E Hoe, G Parnell, P Gatt, SD Schibeci, GJ Stewart, DR Booth PloS one 8 (10), e77508, 2013 | 17 | 2013 |
| Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm. 2014; 1 (4): e40 S Ramanathan, SW Reddel, A Henderson, JD Parratt, M Barnett, PN Gatt, ... | 10 | 2014 |
| Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis N Fewings, PN Gatt, FC McKay, GP Parnell, SD Schibeci, J Edwards, ... Data in brief 11, 364-370, 2017 | 6 | 2017 |
| Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing … R van der Linde, PN Gatt, S Smith, MA Fernandez, L Vaughan, E Blyth, ... Cancers 15 (20), 5064, 2023 | 3 | 2023 |
| Expression of CYP24A1 and other multiple sclerosis risk genes in peripheral blood indicates response to vitamin D in homeostatic and inflammatory conditions SPL Law, PN Gatt, SD Schibeci, FC McKay, S Vucic, P Hart, SN Byrne, ... Genes & Immunity, 1-7, 2021 | 3 | 2021 |
| Correlation of flow cytometric measurable residual disease (FC-MRD) with molecular MRD and clinical outcome at one year in adult B-acute lymphoblastic leukaemia (B-ALL) and … R van der Linde, PN Gatt, S Smith, M Fernandez, L Vaughan, E Blyth, ... Pathology 56, S108, 2024 | | 2024 |
| Autoantibodies, routine and novel markers of neuroinflammation in people with atypical psychiatric disease JX Jiang, N Fewings, P Gatt, S Dervish, M Silsby, AF Fois, S Duma, ... Journal of Affective Disorders Reports 12, 100548, 2023 | | 2023 |
| Multiple Sclerosis Risk Gene Biomarkers for Vitamin D Response SPL Law, P Gatt, SD Schibeci, G Parnell, D Booth MULTIPLE SCLEROSIS JOURNAL 26 (3), NP24-NP25, 2020 | | 2020 |
| Homeostatic Regulation May Limit Immune Response to Vitamin D Supplementation, Especially to Cholecalciferol GP Parnell, PN Gatt, SP Law, SD Schibeci, AP Jones, S Trend, ... MULTIPLE SCLEROSIS JOURNAL 26 (3), NP25-NP26, 2020 | | 2020 |
| Expression of MS risk genes in whole blood of CIS patients treated with narrow band UVB phototherapy P Gatt, RM Lucas, WM Carroll, D Nolan, JM Cole, AP Jones, S Trend, ... Multiple Sclerosis 23 (13), NP14-NP14, 2017 | | 2017 |
| Clinical implications of IL7R genotype: from disease risk to disease management F McKay, PN Gatt, NL Fewings, R Rajasuriar, SR Lewin, D Gottlieb, ... MULTIPLE SCLEROSIS JOURNAL 23 (13), NP18-NP18, 2017 | | 2017 |
| Immunogenetic traits of a heritable CD56+ cell population dysregulated in Multiple sclerosis: clinical utility and implications for pathogenesis D Booth, F McKay, P Gatt, N Fewings, G Parnell, S Schibeci, M Barnett, ... European Journal of Immunology 46 (S1), 286, 2016 | | 2016 |
